Table of Contents 1 Liver Fibrosis Drug Market Overview 1.1 Product Overview and Scope of Liver Fibrosis Drug 1.2 Liver Fibrosis Drug Segment by Type 1.2.1 Global Liver Fibrosis Drug Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Nucleoside 1.2.3 Interferon 1.2.4 Other 1.3 Liver Fibrosis Drug Segment by Application 1.3.1 Liver Fibrosis Drug Sales Comparison by Application: 2020 VS 2026 1.3.2 Hepatitis 1.3.3 Liver Fibrosis 1.3.4 Other 1.4 Global Liver Fibrosis Drug Market Size Estimates and Forecasts 1.4.1 Global Liver Fibrosis Drug Revenue 2015-2026 1.4.2 Global Liver Fibrosis Drug Sales 2015-2026 1.4.3 Liver Fibrosis Drug Market Size by Region: 2020 Versus 2026 2 Global Liver Fibrosis Drug Market Competition by Manufacturers 2.1 Global Liver Fibrosis Drug Sales Market Share by Manufacturers (2015-2020) 2.2 Global Liver Fibrosis Drug Revenue Share by Manufacturers (2015-2020) 2.3 Global Liver Fibrosis Drug Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Liver Fibrosis Drug Manufacturing Sites, Area Served, Product Type 2.5 Liver Fibrosis Drug Market Competitive Situation and Trends 2.5.1 Liver Fibrosis Drug Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Liver Fibrosis Drug Players (Opinion Leaders) 3 Liver Fibrosis Drug Retrospective Market Scenario by Region 3.1 Global Liver Fibrosis Drug Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Liver Fibrosis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Liver Fibrosis Drug Market Facts & Figures by Country 3.3.1 North America Liver Fibrosis Drug Sales by Country 3.3.2 North America Liver Fibrosis Drug Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Liver Fibrosis Drug Market Facts & Figures by Country 3.4.1 Europe Liver Fibrosis Drug Sales by Country 3.4.2 Europe Liver Fibrosis Drug Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Liver Fibrosis Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Liver Fibrosis Drug Sales by Region 3.5.2 Asia Pacific Liver Fibrosis Drug Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Liver Fibrosis Drug Market Facts & Figures by Country 3.6.1 Latin America Liver Fibrosis Drug Sales by Country 3.6.2 Latin America Liver Fibrosis Drug Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Liver Fibrosis Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Liver Fibrosis Drug Sales by Country 3.7.2 Middle East and Africa Liver Fibrosis Drug Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Liver Fibrosis Drug Historic Market Analysis by Type 4.1 Global Liver Fibrosis Drug Sales Market Share by Type (2015-2020) 4.2 Global Liver Fibrosis Drug Revenue Market Share by Type (2015-2020) 4.3 Global Liver Fibrosis Drug Price Market Share by Type (2015-2020) 4.4 Global Liver Fibrosis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Liver Fibrosis Drug Historic Market Analysis by Application 5.1 Global Liver Fibrosis Drug Sales Market Share by Application (2015-2020) 5.2 Global Liver Fibrosis Drug Revenue Market Share by Application (2015-2020) 5.3 Global Liver Fibrosis Drug Price by Application (2015-2020) 6 Company Profiles and Key Figures in Liver Fibrosis Drug Business 6.1 Gilead 6.1.1 Corporation Information 6.1.2 Gilead Description, Business Overview and Total Revenue 6.1.3 Gilead Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Gilead Products Offered 6.1.5 Gilead Recent Development 6.2 Biogen Idec 6.2.1 Biogen Idec Liver Fibrosis Drug Production Sites and Area Served 6.2.2 Biogen Idec Description, Business Overview and Total Revenue 6.2.3 Biogen Idec Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Biogen Idec Products Offered 6.2.5 Biogen Idec Recent Development 6.3 Merck KGaA 6.3.1 Merck KGaA Liver Fibrosis Drug Production Sites and Area Served 6.3.2 Merck KGaA Description, Business Overview and Total Revenue 6.3.3 Merck KGaA Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Merck KGaA Products Offered 6.3.5 Merck KGaA Recent Development 6.4 Bristol-Myers Squibb Company 6.4.1 Bristol-Myers Squibb Company Liver Fibrosis Drug Production Sites and Area Served 6.4.2 Bristol-Myers Squibb Company Description, Business Overview and Total Revenue 6.4.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Bristol-Myers Squibb Company Products Offered 6.4.5 Bristol-Myers Squibb Company Recent Development 6.5 Roche 6.5.1 Roche Liver Fibrosis Drug Production Sites and Area Served 6.5.2 Roche Description, Business Overview and Total Revenue 6.5.3 Roche Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Roche Products Offered 6.5.5 Roche Recent Development 6.6 Merck & Co. 6.6.1 Merck & Co. Liver Fibrosis Drug Production Sites and Area Served 6.6.2 Merck & Co. Description, Business Overview and Total Revenue 6.6.3 Merck & Co. Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Merck & Co. Products Offered 6.6.5 Merck & Co. Recent Development 6.7 Tri-Prime 6.6.1 Tri-Prime Liver Fibrosis Drug Production Sites and Area Served 6.6.2 Tri-Prime Description, Business Overview and Total Revenue 6.6.3 Tri-Prime Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Tri-Prime Products Offered 6.7.5 Tri-Prime Recent Development 7 Liver Fibrosis Drug Manufacturing Cost Analysis 7.1 Liver Fibrosis Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Liver Fibrosis Drug 7.4 Liver Fibrosis Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Liver Fibrosis Drug Distributors List 8.3 Liver Fibrosis Drug Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Liver Fibrosis Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Liver Fibrosis Drug by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Liver Fibrosis Drug by Type (2021-2026) 10.2 Liver Fibrosis Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Liver Fibrosis Drug by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Liver Fibrosis Drug by Application (2021-2026) 10.3 Liver Fibrosis Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Liver Fibrosis Drug by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Liver Fibrosis Drug by Region (2021-2026) 10.4 North America Liver Fibrosis Drug Estimates and Projections (2021-2026) 10.5 Europe Liver Fibrosis Drug Estimates and Projections (2021-2026) 10.6 Asia Pacific Liver Fibrosis Drug Estimates and Projections (2021-2026) 10.7 Latin America Liver Fibrosis Drug Estimates and Projections (2021-2026) 10.8 Middle East and Africa Liver Fibrosis Drug Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Liver Fibrosis Drug Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Liver Fibrosis Drug Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Liver Fibrosis Drug Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Liver Fibrosis Drug Manufacturers Covered in This Study Table 5. Global Liver Fibrosis Drug Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Liver Fibrosis Drug Sales Share by Manufacturers (2015-2020) Table 7. Global Liver Fibrosis Drug Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Liver Fibrosis Drug Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Liver Fibrosis Drug Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Liver Fibrosis Drug Sales Sites and Area Served Table 11. Manufacturers Liver Fibrosis Drug Product Types Table 12. Global Liver Fibrosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Liver Fibrosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Fibrosis Drug as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Liver Fibrosis Drug Players Table 16. Global Liver Fibrosis Drug Sales (K Units) by Region (2015-2020) Table 17. Global Liver Fibrosis Drug Sales Market Share by Region (2015-2020) Table 18. Global Liver Fibrosis Drug Revenue (Million US$) by Region (2015-2020) Table 19. Global Liver Fibrosis Drug Revenue Market Share by Region (2015-2020) Table 20. North America Liver Fibrosis Drug Sales by Country (2015-2020) (K Units) Table 21. North America Liver Fibrosis Drug Sales Market Share by Country (2015-2020) Table 22. North America Liver Fibrosis Drug Revenue by Country (2015-2020) (US$ Million) Table 23. North America Liver Fibrosis Drug Revenue Market Share by Country (2015-2020) Table 24. Europe Liver Fibrosis Drug Sales by Country (2015-2020) (K Units) Table 25. Europe Liver Fibrosis Drug Sales Market Share by Country (2015-2020) Table 26. Europe Liver Fibrosis Drug Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Liver Fibrosis Drug Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Liver Fibrosis Drug Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Liver Fibrosis Drug Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Liver Fibrosis Drug Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Liver Fibrosis Drug Revenue Market Share by Region (2015-2020) Table 32. Latin America Liver Fibrosis Drug Sales by Country (2015-2020) (K Units) Table 33. Latin America Liver Fibrosis Drug Sales Market Share by Country (2015-2020) Table 34. Latin America Liver Fibrosis Drug Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Liver Fibrosis Drug Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Liver Fibrosis Drug Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Liver Fibrosis Drug Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Liver Fibrosis Drug Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Country (2015-2020) Table 40. Global Liver Fibrosis Drug Sales (K Units) by Type (2015-2020) Table 41. Global Liver Fibrosis Drug Sales Share by Type (2015-2020) Table 42. Global Liver Fibrosis Drug Revenue (Million US$) by Type (2015-2020) Table 43. Global Liver Fibrosis Drug Revenue Share by Type (2015-2020) Table 44. Global Liver Fibrosis Drug Price (USD/Unit) by Type (2015-2020) Table 45. Global Liver Fibrosis Drug Sales (K Units) by Application (2015-2020) Table 46. Global Liver Fibrosis Drug Sales Market Share by Application (2015-2020) Table 47. Global Liver Fibrosis Drug Sales Growth Rate by Application (2015-2020) Table 48. Gilead Liver Fibrosis Drug Corporation Information Table 49. Gilead Description and Business Overview Table 50. Gilead Liver Fibrosis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Gilead Main Product Table 52. Gilead Recent Development Table 53. Biogen Idec Liver Fibrosis Drug Corporation Information Table 54. Biogen Idec Corporation Information Table 55. Biogen Idec Liver Fibrosis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Biogen Idec Main Product Table 57. Biogen Idec Recent Development Table 58. Merck KGaA Liver Fibrosis Drug Corporation Information Table 59. Merck KGaA Corporation Information Table 60. Merck KGaA Liver Fibrosis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Merck KGaA Main Product Table 62. Merck KGaA Recent Development Table 63. Bristol-Myers Squibb Company Liver Fibrosis Drug Corporation Information Table 64. Bristol-Myers Squibb Company Corporation Information Table 65. Bristol-Myers Squibb Company Liver Fibrosis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Bristol-Myers Squibb Company Main Product Table 67. Bristol-Myers Squibb Company Recent Development Table 68. Roche Liver Fibrosis Drug Corporation Information Table 69. Roche Corporation Information Table 70. Roche Liver Fibrosis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Roche Main Product Table 72. Roche Recent Development Table 73. Merck & Co. Liver Fibrosis Drug Corporation Information Table 74. Merck & Co. Corporation Information Table 75. Merck & Co. Liver Fibrosis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Merck & Co. Main Product Table 77. Merck & Co. Recent Development Table 78. Tri-Prime Liver Fibrosis Drug Corporation Information Table 79. Tri-Prime Corporation Information Table 80. Tri-Prime Liver Fibrosis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Tri-Prime Main Product Table 82. Tri-Prime Recent Development Table 83. Sales Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Liver Fibrosis Drug Distributors List Table 86. Liver Fibrosis Drug Customers List Table 87. Market Key Trends Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 89. Key Challenges Table 90. Global Liver Fibrosis Drug Sales (K Units) Forecast by Type (2021-2026) Table 91. Global Liver Fibrosis Drug Sales Market Share Forecast by Type (2021-2026) Table 92. Global Liver Fibrosis Drug Revenue (Million US$) Forecast by Type (2021-2026) Table 93. Global Liver Fibrosis Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 94. Global Liver Fibrosis Drug Sales (K Units) Forecast by Application (2021-2026) Table 95. Global Liver Fibrosis Drug Revenue (Million US$) Forecast by Application (2021-2026) Table 96. Global Liver Fibrosis Drug Sales (K Units) Forecast by Region (2021-2026) Table 97. Global Liver Fibrosis Drug Sales Market Share Forecast by Region (2021-2026) Table 98. Global Liver Fibrosis Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 99. Global Liver Fibrosis Drug Revenue Market Share Forecast by Region (2021-2026) Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Liver Fibrosis Drug Figure 2. Global Liver Fibrosis Drug Sales Market Share by Type: 2020 VS 2026 Figure 3. Nucleoside Product Picture Figure 4. Interferon Product Picture Figure 5. Other Product Picture Figure 6. Global Liver Fibrosis Drug Consumption Market Share by Application: 2020 VS 2026 Figure 7. Hepatitis Figure 8. Liver Fibrosis Figure 9. Other Figure 10. Global Liver Fibrosis Drug Market Size 2015-2026 (US$ Million) Figure 11. Global Liver Fibrosis Drug Sales Capacity (K Units) (2015-2026) Figure 12. Global Liver Fibrosis Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Liver Fibrosis Drug Sales Share by Manufacturers in 2020 Figure 14. Global Liver Fibrosis Drug Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Liver Fibrosis Drug Revenue in 2019 Figure 16. Liver Fibrosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Liver Fibrosis Drug Sales Market Share by Region (2015-2020) Figure 18. Global Liver Fibrosis Drug Sales Market Share by Region in 2019 Figure 19. Global Liver Fibrosis Drug Revenue Market Share by Region (2015-2020) Figure 20. Global Liver Fibrosis Drug Revenue Market Share by Region in 2019 Figure 21. North America Liver Fibrosis Drug Sales Market Share by Country in 2019 Figure 22. North America Liver Fibrosis Drug Revenue Market Share by Country in 2019 Figure 23. U.S. Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 24. U.S. Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 26. Canada Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Liver Fibrosis Drug Sales Market Share by Country in 2019 Figure 28. Europe Liver Fibrosis Drug Revenue Market Share by Country in 2019 Figure 29. Germany Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 30. Germany Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 32. France Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 34. U.K. Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 36. Italy Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 38. Russia Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Liver Fibrosis Drug Sales Market Share by Region in 2019 Figure 40. Asia Pacific Liver Fibrosis Drug Revenue Market Share by Region in 2019 Figure 41. China Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 42. China Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 44. Japan Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 46. South Korea Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 48. India Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 50. Australia Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 52. Taiwan Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 54. Indonesia Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 56. Thailand Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 58. Malaysia Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 60. Philippines Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 62. Vietnam Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Liver Fibrosis Drug Sales Market Share by Country in 2019 Figure 64. Latin America Liver Fibrosis Drug Revenue Market Share by Country in 2019 Figure 65. Mexico Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 66. Mexico Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 68. Brazil Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 70. Argentina Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Liver Fibrosis Drug Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Country in 2019 Figure 73. Turkey Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 74. Turkey Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 76. Saudi Arabia Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Liver Fibrosis Drug Sales Growth Rate (2015-2020) (K Units) Figure 78. U.A.E Liver Fibrosis Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Liver Fibrosis Drug by Type (2015-2020) Figure 80. Sales Market Share of Liver Fibrosis Drug by Type in 2019 Figure 81. Revenue Share of Liver Fibrosis Drug by Type (2015-2020) Figure 82. Revenue Market Share of Liver Fibrosis Drug by Type in 2019 Figure 83. Global Liver Fibrosis Drug Sales Growth by Type (2015-2020) (K Units) Figure 84. Global Liver Fibrosis Drug Sales Market Share by Application (2015-2020) Figure 85. Global Liver Fibrosis Drug Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Liver Fibrosis Drug by Application (2015-2020) Figure 87. Global Revenue Share of Liver Fibrosis Drug by Application in 2020 Figure 88. Gilead Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Tri-Prime Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Price Trend of Key Raw Materials Figure 96. Manufacturing Cost Structure of Liver Fibrosis Drug Figure 97. Manufacturing Process Analysis of Liver Fibrosis Drug Figure 98. Liver Fibrosis Drug Industrial Chain Analysis Figure 99. Channels of Distribution Figure 100. Distributors Profiles Figure 101. Porter's Five Forces Analysis Figure 102. North America Liver Fibrosis Drug Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 103. North America Liver Fibrosis Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Europe Liver Fibrosis Drug Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 105. Europe Liver Fibrosis Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Latin America Liver Fibrosis Drug Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 107. Latin America Liver Fibrosis Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa Liver Fibrosis Drug Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 109. Middle East and Africa Liver Fibrosis Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific Liver Fibrosis Drug Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 111. Asia Pacific Liver Fibrosis Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

Gilead Biogen Idec Merck KGaA Bristol-Myers Squibb Company Roche Merck & Co. Tri-Prime